Lukas biomedical Inc.(TW:6814)
NT$17.60+0.10 (+0.57%)
TW:6814
Lukas biomedical Inc. financials statements
NT$17.60
At close:+0.10 (+0.57%)
Lukas biomedical Inc. (6814) Financial Statements
Lukas biomedical Inc. Financial Overview
Lukas biomedical Inc.'s market cap is currently NT$732.80M. The company's EPS TTM is NT$-2.20; its P/E ratio is -8.00; Lukas biomedical Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 179.49M | NT$ 189.83M | NT$ 231.83M | NT$ 184.79M | NT$ 157.62M |
| Gross Profit | NT$ 95.69M | NT$ 113.12M | NT$ 133.89M | NT$ 97.91M | NT$ 96.06M |
| Operating Income | NT$ -81.16M | NT$ -92.14M | NT$ -43.56M | NT$ -48.47M | NT$ -43.06M |
| EBITDA | NT$ -56.12M | NT$ -62.88M | NT$ -12.57M | NT$ -10.93M | NT$ -361.00K |
| Net Income | NT$ -85.63M | NT$ -94.38M | NT$ -47.35M | NT$ -50.07M | NT$ -49.49M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 34.75M | NT$ 64.71M | NT$ 31.80M | NT$ 40.26M | NT$ 64.81M |
| Total Assets | NT$ 426.80M | NT$ 476.50M | NT$ 441.19M | NT$ 479.67M | NT$ 531.24M |
| Total Debt | NT$ 156.02M | NT$ 115.20M | NT$ 125.86M | NT$ 112.42M | NT$ 221.47M |
| Net Debt | NT$ 121.27M | NT$ 50.48M | NT$ 94.06M | NT$ 72.16M | NT$ 156.66M |
| Total Liabilities | NT$ 186.62M | NT$ 150.68M | NT$ 161.06M | NT$ 152.18M | NT$ 244.57M |
| Stockholders' Equity | NT$ 240.19M | NT$ 325.82M | NT$ 280.13M | NT$ 327.49M | NT$ 286.68M |
| Cash Flow | |||||
| Free Cash Flow | NT$ -69.95M | NT$ -77.35M | NT$ -14.41M | NT$ -10.41M | NT$ -26.18M |
| Operating Cash Flow | NT$ -61.43M | NT$ -70.53M | NT$ -11.75M | NT$ -7.44M | NT$ -16.16M |
| Investing Cash Flow | NT$ -8.64M | NT$ -9.79M | NT$ -1.66M | NT$ 2.87M | NT$ -10.33M |
| Financing Cash Flow | NT$ 40.10M | NT$ 113.24M | NT$ 4.94M | NT$ -19.98M | NT$ 52.25M |
Currency in TWD

